Evidence map›Paper›PMID 38984425›Full record

ArticleCancer communications (London, England)2024

Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma.

Sangyeop Hyun, Youngmin Han, Jae Yun Moon, Young-Ah Suh, Won-Gun Yun, Wooil Kwon, Jong-Eun Lee, Daeun Kim, Ja-Lok Ku, Jin-Young Jang and 1 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sangyeop HyunDepartment of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
Youngmin HanDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jae Yun MoonMolecular Science and Technology Research Center, Ajou University, Suwon, Republic of Korea.
Young-Ah SuhDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Won-Gun YunDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Wooil KwonDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jong-Eun LeeDNA Link Inc., Seoul, Republic of Korea.
Daeun KimDepartment of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
Ja-Lok KuKorean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jin-Young JangDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Daechan ParkDepartment of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.ORCID 0000-0003-4991-5247

Funding

DNA Link, Inc.Ministry of Education RS-2023-00285390Ministry of Science and ICT 2022R1A2C2011122Ministry of Science and ICT RS-2024-00341899National Research Foundation of Korea
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsAnimalsDisease Models, AnimalHeterograftsHumansMiceXenograft Model Antitumor Assays

Identifiers

PMID38984425
PMCPMC11337908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.